Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 84

1.

Characteristics and Outcomes of Patients With Aortic Stenosis and Chronic Kidney Disease.

Patel KK, Shah SY, Arrigain S, Jolly S, Schold JD, Navaneethan SD, Griffin BP, Nally JV, Desai MY.

J Am Heart Assoc. 2019 Feb 5;8(3):e009980. doi: 10.1161/JAHA.118.009980.

2.

What are the Risk Factors for One-Year Mortality in Older Patients with Chronic Kidney Disease? An Analysis of the Cleveland Clinic CKD Registry.

Saeed F, Arrigain S, Schold JD, Nally JV Jr, Navaneethan SD.

Nephron. 2019;141(2):98-104. doi: 10.1159/000494298. Epub 2018 Nov 21. Review.

PMID:
30463082
3.

Intra-Arterial versus Intravenous Contrast and Renal Injury in Chronic Kidney Disease: A Propensity-Matched Analysis.

Chaudhury P, Armanyous S, Harb SC, Ferreira Provenzano L, Ashour T, Jolly SE, Arrigain S, Konig V, Schold JD, Navaneethan SD, Nally JV Jr, Nakhoul GN.

Nephron. 2019;141(1):31-40. doi: 10.1159/000494047. Epub 2018 Oct 26.

PMID:
30368506
4.

2017 ACC/AHA hypertension guidelines: Toward tighter control.

Blonsky R, Pohl M, Nally JV, Thomas G.

Cleve Clin J Med. 2018 Oct;85(10):771-778. doi: 10.3949/ccjm.85a.18028. No abstract available.

5.

Phosphorus binders: The new and the old, and how to choose.

Sekar A, Kaur T, Nally JV, Rincon-Choles H, Jolly S, Nakhoul GN.

Cleve Clin J Med. 2018 Aug;85(8):629-638. doi: 10.3949/ccjm.85a.17054. Review.

6.

Cause-Specific Mortality in Patients with Chronic Kidney Disease and Atrial Fibrillation.

Airy M, Schold JD, Jolly SE, Arrigain S, Bansal N, Winkelmayer WC, Nally JV Jr, Navaneethan SD.

Am J Nephrol. 2018;48(1):36-45. doi: 10.1159/000491023. Epub 2018 Jul 26.

7.

High-density lipoprotein cholesterol and causes of death in chronic kidney disease.

Navaneethan SD, Schold JD, Walther CP, Arrigain S, Jolly SE, Virani SS, Winkelmayer WC, Nally JV Jr.

J Clin Lipidol. 2018 Jul - Aug;12(4):1061-1071.e7. doi: 10.1016/j.jacl.2018.03.085. Epub 2018 Mar 30.

8.

Chronic kidney disease in African Americans: Puzzle pieces are falling into place.

Nally JV Jr.

Cleve Clin J Med. 2017 Nov;84(11):855-862. doi: 10.3949/ccjm.84gr.17007. Review.

9.

Impact of Uric Acid Levels on Kidney Disease Progression.

Rincon-Choles H, Jolly SE, Arrigain S, Konig V, Schold JD, Nakhoul G, Navaneethan SD, Nally JV Jr, Rothberg MB.

Am J Nephrol. 2017;46(4):315-322. doi: 10.1159/000481460. Epub 2017 Oct 13.

PMID:
29032376
10.

Pragmatic Randomized, Controlled Trial of Patient Navigators and Enhanced Personal Health Records in CKD.

Navaneethan SD, Jolly SE, Schold JD, Arrigain S, Nakhoul G, Konig V, Hyland J, Burrucker YK, Dann PD, Tucky BH, Sharp J, Nally JV.

Clin J Am Soc Nephrol. 2017 Sep 7;12(9):1418-1427. doi: 10.2215/CJN.02100217. Epub 2017 Aug 4.

11.

Blood pressure parameters are associated with all-cause and cause-specific mortality in chronic kidney disease.

Navaneethan SD, Schold JD, Jolly SE, Arrigain S, Blum MF, Winkelmayer WC, Nally JV Jr.

Kidney Int. 2017 Nov;92(5):1272-1281. doi: 10.1016/j.kint.2017.04.030. Epub 2017 Jul 24.

12.

Diabetes Control and the Risks of ESRD and Mortality in Patients With CKD.

Navaneethan SD, Schold JD, Jolly SE, Arrigain S, Winkelmayer WC, Nally JV Jr.

Am J Kidney Dis. 2017 Aug;70(2):191-198. doi: 10.1053/j.ajkd.2016.11.018. Epub 2017 Feb 10.

13.

Outcomes of In-Hospital Cardiopulmonary Resuscitation in Patients with CKD.

Saeed F, Adil MM, Kaleem UM, Zafar TT, Khan AS, Holley JL, Nally JV Jr.

Clin J Am Soc Nephrol. 2016 Oct 7;11(10):1744-1751. doi: 10.2215/CJN.07530715. Epub 2016 Jul 21.

14.

In Reply: Blood pressure targets.

Thomas G, Nally JV, Pohl MA.

Cleve Clin J Med. 2016 Jul;83(7):488-9. doi: 10.3949/ccjm.83c.07003. No abstract available.

15.

Associations of dysnatremias with mortality in chronic kidney disease.

Huang H, Jolly SE, Airy M, Arrigain S, Schold JD, Nally JV, Navaneethan SD.

Nephrol Dial Transplant. 2017 Jul 1;32(7):1204-1210. doi: 10.1093/ndt/gfw209.

16.

Interpreting SPRINT: How low should you go?

Thomas G, Nally JV, Pohl MA.

Cleve Clin J Med. 2016 Mar;83(3):187-95. doi: 10.3949/ccjm.83a.15175. Review.

17.

Mortality Outcomes of Patients with Chronic Kidney Disease and Chronic Obstructive Pulmonary Disease.

Navaneethan SD, Schold JD, Huang H, Nakhoul G, Jolly SE, Arrigain S, Dweik RA, Nally JV Jr.

Am J Nephrol. 2016;43(1):39-46. doi: 10.1159/000444422. Epub 2016 Feb 19.

18.

Body mass index and causes of death in chronic kidney disease.

Navaneethan SD, Schold JD, Arrigain S, Kirwan JP, Nally JV Jr.

Kidney Int. 2016 Mar;89(3):675-82. doi: 10.1016/j.kint.2015.12.002. Epub 2016 Jan 12.

19.

Should all patients with significant proteinuria take a renin-angiotensin inhibitor?

Thomas G, Nally JV.

Cleve Clin J Med. 2015 Nov;82(11):716-8. doi: 10.3949/ccjm.82a.15038. Review. No abstract available.

20.

Serum Potassium, End-Stage Renal Disease and Mortality in Chronic Kidney Disease.

Nakhoul GN, Huang H, Arrigain S, Jolly SE, Schold JD, Nally JV Jr, Navaneethan SD.

Am J Nephrol. 2015;41(6):456-63. doi: 10.1159/000437151. Epub 2015 Jul 25.

21.

Implantable cardioverter-defibrillators in patients with CKD: a propensity-matched mortality analysis.

Nakhoul GN, Schold JD, Arrigain S, Harb SC, Jolly S, Wilkoff BL, Nally JV Jr, Navaneethan SD.

Clin J Am Soc Nephrol. 2015 Jul 7;10(7):1119-27. doi: 10.2215/CJN.11121114. Epub 2015 Jun 25.

22.

Renal resistive index and mortality in chronic kidney disease.

Toledo C, Thomas G, Schold JD, Arrigain S, Gornik HL, Nally JV, Navaneethan SD.

Hypertension. 2015 Aug;66(2):382-8. doi: 10.1161/HYPERTENSIONAHA.115.05536. Epub 2015 Jun 15.

23.

Cause-Specific Deaths in Non-Dialysis-Dependent CKD.

Navaneethan SD, Schold JD, Arrigain S, Jolly SE, Nally JV Jr.

J Am Soc Nephrol. 2015 Oct;26(10):2512-20. doi: 10.1681/ASN.2014101034. Epub 2015 Jun 4.

24.

Development of a chronic kidney disease patient navigator program.

Jolly SE, Navaneethan SD, Schold JD, Arrigain S, Konig V, Burrucker YK, Hyland J, Dann P, Tucky BH, Sharp JW, Nally JV.

BMC Nephrol. 2015 May 3;16:69. doi: 10.1186/s12882-015-0060-2.

25.

Renal failure requiring dialysis complicating slow continuous ultrafiltration in acute heart failure: importance of systolic perfusion pressure.

Wehbe E, Patarroyo M, Taliercio JJ, Starling RC, Nally JV Jr, Tang WH, Demirjian S.

J Card Fail. 2015 Feb;21(2):108-15. doi: 10.1016/j.cardfail.2014.10.005. Epub 2014 Oct 15.

PMID:
25463414
26.

Practice patterns of phosphate binder use and their associations with mortality in chronic kidney disease.

Navaneethan SD, Sakhuja A, Arrigain S, Sharp J, Schold JD, Nally JV Jr.

Clin Nephrol. 2014 Jul;82(1):16-25. doi: 10.5414/CN108144.

PMID:
24887302
27.

Serum testosterone levels and mortality in men with CKD stages 3-4.

Khurana KK, Navaneethan SD, Arrigain S, Schold JD, Nally JV Jr, Shoskes DA.

Am J Kidney Dis. 2014 Sep;64(3):367-74. doi: 10.1053/j.ajkd.2014.03.010. Epub 2014 Apr 13.

28.

Chronic kidney disease in an electronic health record problem list: quality of care, ESRD, and mortality.

Jolly SE, Navaneethan SD, Schold JD, Arrigain S, Sharp JW, Jain AK, Schreiber MJ, Simon JF, Nally JV.

Am J Nephrol. 2014;39(4):288-96. doi: 10.1159/000360306. Epub 2014 Apr 1.

29.

New hypertension guidelines: one size fits most?

Thomas G, Shishehbor M, Brill D, Nally JV Jr.

Cleve Clin J Med. 2014 Mar;81(3):178-88. doi: 10.3949/ccjm.81a.14003.

PMID:
24591473
30.

Presence and outcomes of kidney disease in patients with pulmonary hypertension.

Navaneethan SD, Wehbe E, Heresi GA, Gaur V, Minai OA, Arrigain S, Nally JV Jr, Schold JD, Rahman M, Dweik RA.

Clin J Am Soc Nephrol. 2014 May;9(5):855-63. doi: 10.2215/CJN.10191013. Epub 2014 Feb 27.

31.

Comparative effectiveness of early versus conventional timing of dialysis initiation in advanced CKD.

Crews DC, Scialla JJ, Boulware LE, Navaneethan SD, Nally JV Jr, Liu X, Arrigain S, Schold JD, Ephraim PL, Jolly SE, Sozio SM, Michels WM, Miskulin DC, Tangri N, Shafi T, Wu AW, Bandeen-Roche K; DEcIDE Network Patient Outcomes in End Stage Renal Disease Study Investigators.

Am J Kidney Dis. 2014 May;63(5):806-15. doi: 10.1053/j.ajkd.2013.12.010. Epub 2014 Feb 6.

32.

Albuminuria: when urine predicts kidney and cardiovascular disease.

Stephen R, Jolly SE, Nally JV Jr, Navaneethan SD.

Cleve Clin J Med. 2014 Jan;81(1):41-50. doi: 10.3949/ccjm.81a.13040. Review.

PMID:
24391106
33.

Prognostic importance of serum alkaline phosphatase in CKD stages 3-4 in a clinical population.

Taliercio JJ, Schold JD, Simon JF, Arrigain S, Tang A, Saab G, Nally JV Jr, Navaneethan SD.

Am J Kidney Dis. 2013 Oct;62(4):703-10. doi: 10.1053/j.ajkd.2013.04.012. Epub 2013 Jun 12.

34.

Cardiac resynchronization therapy in CKD: a systematic review.

Garg N, Thomas G, Jackson G, Rickard J, Nally JV Jr, Tang WH, Navaneethan SD.

Clin J Am Soc Nephrol. 2013 Aug;8(8):1293-303. doi: 10.2215/CJN.00750113. Epub 2013 May 9. Review.

35.

Metabolic syndrome, ESRD, and death in CKD.

Navaneethan SD, Schold JD, Kirwan JP, Arrigain S, Jolly SE, Poggio ED, Beddhu S, Nally JV Jr.

Clin J Am Soc Nephrol. 2013 Jun;8(6):945-52. doi: 10.2215/CJN.09870912. Epub 2013 Feb 14.

36.

Electronic health records: a new tool to combat chronic kidney disease?

Navaneethan SD, Jolly SE, Sharp J, Jain A, Schold JD, Schreiber MJ Jr, Nally JV Jr.

Clin Nephrol. 2013 Mar;79(3):175-83. doi: 10.5414/CN107757.

37.

Renal denervation to treat resistant hypertension: Guarded optimism.

Thomas G, Shishehbor MH, Bravo EL, Nally JV.

Cleve Clin J Med. 2012 Jul;79(7):501-10. doi: 10.3949/ccjm.79a.12040.

PMID:
22751635
38.

Serum triglycerides and risk for death in Stage 3 and Stage 4 chronic kidney disease.

Navaneethan SD, Schold JD, Arrigain S, Thomas G, Jolly SE, Poggio ED, Schreiber MJ Jr, Sarnak MJ, Nally JV Jr.

Nephrol Dial Transplant. 2012 Aug;27(8):3228-34. doi: 10.1093/ndt/gfs058. Epub 2012 May 2.

39.

Finding the cause of acute kidney injury: which index of fractional excretion is better?

Gotfried J, Wiesen J, Raina R, Nally JV Jr.

Cleve Clin J Med. 2012 Feb;79(2):121-6. doi: 10.3949/ccjm.79a.11030. Review.

PMID:
22301562
40.

Unusual cases of hydronephrosis with retroperitoneal fibrosis: mystery revealed.

Raina R, Simon JF, Marion CR, Valeria A, Navaneethan SD, Heresi GA, Guzman JA, Wehbe E, Nally JV.

NDT Plus. 2011 Oct;4(5):313-317. Epub 2011 Jul 25. No abstract available.

41.

Serum bicarbonate and mortality in stage 3 and stage 4 chronic kidney disease.

Navaneethan SD, Schold JD, Arrigain S, Jolly SE, Wehbe E, Raina R, Simon JF, Srinivas TR, Jain A, Schreiber MJ Jr, Nally JV Jr.

Clin J Am Soc Nephrol. 2011 Oct;6(10):2395-402. doi: 10.2215/CJN.03730411. Epub 2011 Sep 1.

42.

Low 25-hydroxyvitamin D levels and mortality in non-dialysis-dependent CKD.

Navaneethan SD, Schold JD, Arrigain S, Jolly SE, Jain A, Schreiber MJ Jr, Simon JF, Srinivas TR, Nally JV Jr.

Am J Kidney Dis. 2011 Oct;58(4):536-43. doi: 10.1053/j.ajkd.2011.04.028. Epub 2011 Aug 4.

43.

Implications of the CKD-EPI GFR estimation equation in clinical practice.

Schold JD, Navaneethan SD, Jolly SE, Poggio ED, Arrigain S, Saupe W, Jain A, Sharp JW, Simon JF, Schreiber MJ Jr, Nally JV Jr.

Clin J Am Soc Nephrol. 2011 Mar;6(3):497-504. doi: 10.2215/CJN.04240510. Epub 2010 Nov 29.

44.

Development and validation of an electronic health record-based chronic kidney disease registry.

Navaneethan SD, Jolly SE, Schold JD, Arrigain S, Saupe W, Sharp J, Lyons J, Simon JF, Schreiber MJ Jr, Jain A, Nally JV Jr.

Clin J Am Soc Nephrol. 2011 Jan;6(1):40-9. doi: 10.2215/CJN.04230510. Epub 2010 Nov 4.

45.

Referral patterns of primary care physicians for chronic kidney disease in general population and geriatric patients.

Navaneethan SD, Kandula P, Jeevanantham V, Nally JV Jr, Liebman SE.

Clin Nephrol. 2010 Apr;73(4):260-7.

PMID:
20353733
46.

Renal denervation for resistant hypertension.

Bravo EL, Rafey MA, Nally JV Jr.

Am J Kidney Dis. 2009 Nov;54(5):795-7. doi: 10.1053/j.ajkd.2009.07.005. Epub 2009 Sep 6. No abstract available.

PMID:
19733949
47.

The management of renal artery atherosclerosis for renal salvage: does stenting help?

Kashyap VS, Sepulveda RN, Bena JF, Nally JV, Poggio ED, Greenberg RK, Yadav JS, Ouriel K.

J Vasc Surg. 2007 Jan;45(1):101-8; discussion 108-9.

49.

Renal failure secondary to acute tubular necrosis: epidemiology, diagnosis, and management.

Gill N, Nally JV Jr, Fatica RA.

Chest. 2005 Oct;128(4):2847-63. Review.

PMID:
16236963
50.

Staghorn calculus in renal allograft presenting as acute renal failure.

Thakar CV, Lara A, Goel M, Nally JV Jr.

Urol Res. 2003 Dec;31(6):414-6. Epub 2003 Sep 24.

PMID:
14508619

Supplemental Content

Loading ...
Support Center